The cost of cancer care: how much would you pay for your drugs? Patient and oncology professional stakeholder opinions in Ireland
Irish Journal of Medical Science (1971 -) · 2026-10 · 195 (5) · 2623-2632
DOI: 10.1007/s11845-026-04468-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 06.06.2026. Verfasst von Ruth Kieran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cork University Hospital, Cork, Ireland. kieranr@tcd.ie. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit nennt 56 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: An incremental cost-effectiveness ratio (ICER) threshold of €45,000/Quality-Adjusted-Life-Year (QALY) is used in the assessment of new drugs in Ireland. We assessed stakeholder perceptions of this, and willingness-to-pay for new drugs. METHODS: We surveyed oncology patients (n = 125), oncologists, pharmacists, and nurses (n = 61, April-July 2023). Participants reviewed 9 hypothetical scenarios, including costs and survival outcomes with 'current treatments', alongside information about a 'better' drug, and estimated how much the state should pay (5 scenarios). RESULTS: In most cases, willingness-to-pay exceeded current thresholds. Staff thresholds (overall median €52,264/QALY, IQR €13,671 - 108,000) were more conservative than patients (€90,857/QALY, €13,671 - 216,000) for almost all scenarios. Both staff and patients would pay more for overall survival benefit than quality of life benefit. Providing more biographical information increased patient thresholds (€224,571, IQR €90,857-€558,857) but not staff. Patient median threshold was €816,000 per recurrence prevented (IQR €240,000-1,776,000). CONCLUSIONS: We demonstrate stakeholder desire for an increase in spending thresholds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Cork University Hospital, Cork, Ireland. kieranr@tcd.ie.
- Cancer Research@UCC, College of Medicine & Health, University College Cork, Cork, Ireland. kieranr@tcd.ie.
- Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
- Cancer Research@UCC, College of Medicine & Health, University College Cork, Cork, Ireland.
- Department of Pharmacy, Cork University Hospital, Cork, Ireland.
- Department of Medical Oncology, St Vincents University Hospital, Dublin, Ireland.
Zitieren
APA
Kieran, R., Coakley, K., Macanovic, B., Weadick, C., Keogh, R., Cooke, K., Allen, M., Higgins, M., & O'Reilly, S. (2026). The cost of cancer care: how much would you pay for your drugs? Patient and oncology professional stakeholder opinions in Ireland. Irish Journal of Medical Science (1971 -), 195(5), 2623-2632. https://doi.org/10.1007/s11845-026-04468-y
Vancouver
Kieran R, Coakley K, Macanovic B, Weadick C, Keogh R, Cooke K, et al. The cost of cancer care: how much would you pay for your drugs? Patient and oncology professional stakeholder opinions in Ireland. Irish Journal of Medical Science (1971 -). 2026;195(5):2623-2632. doi:10.1007/s11845-026-04468-y
BibTeX
@article{Kieran2026,
author = {Kieran, Ruth and Coakley, Kate and Macanovic, Bojan and Weadick, Catherine and Keogh, Rachel and Cooke, Katie and Allen, Margaret and Higgins, Michaela and O'Reilly, Seamus},
title = {The cost of cancer care: how much would you pay for your drugs? Patient and oncology professional stakeholder opinions in Ireland},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
volume = {195},
number = {5},
pages = {2623--2632},
doi = {10.1007/s11845-026-04468-y}
}
EUVIMED